Meg Krench is an experienced professional in the biotechnology and neuroscience sectors, currently serving as a Board Observer for multiple companies, including Stealth Neuro, Draig Therapeutics, Eligo Bioscience, QurAlis, and Normunity. In addition, Meg holds the position of Board Director at VERALOX Therapeutics and Co-Chair at New England Venture Network. Since August 2021, Meg has also been an Investor at Sanofi Ventures. Meg's educational background includes a PhD in Neuroscience from the Massachusetts Institute of Technology and a Bachelor's degree in Biology and Neuroscience from Penn State University. An emphasis on developing innovative therapies for neuropsychiatric conditions and other critical health issues defines Meg's contributions to the industry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices